Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABS
- CUSIP Number: 78397t202
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 11M | $43M | 0% | Dec 2025 |
|
| Commodore Capital | 4.4M | $17M | 0% | Dec 2025 |
|
| RA Capital Management | 4.4M | $8.8M | 100% | Sep 2025 |
|
| Woodline Partners | 2.9M | $11M | 0% | Dec 2025 |
|
| Sessa Capital IM | 2.2M | $8.2M | 0% | Dec 2025 |
|
| Vanguard Group | 1.8M | $6.9M | 405% | Dec 2025 |
|
| BVF | 933k | $1.9M | 2% | Sep 2025 |
|
| Propel Bio Management | 653k | $2.4M | 100% | Dec 2025 |
|
| Leucadia National Corporation | 580k | $2.2M | 100% | Dec 2025 |
|
| HB Wealth Management | 308k | $1.2M | 0% | Dec 2025 |
|
| Marshall Wace | 237k | $884k | 100% | Dec 2025 |
|
| Simplify Asset Management | 208k | $779k | 100% | Dec 2025 |
|
| AWM Investment Company | 200k | $748k | 0% | Dec 2025 |
|
| Stempoint Capital | 147k | $548k | 100% | Dec 2025 |
|
| Geode Capital Management | 120k | $447k | 39% | Dec 2025 |
|
| ExodusPoint Capital Management | 86k | $322k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 51k | $192k | 358% | Dec 2025 |
|
| Pathstone Holdings | 51k | $189k | 0% | Dec 2025 |
|
| OMERS Administration Corporation | 42k | $157k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 31k | $117k | 100% | Dec 2025 |
|
| Verition Fund Management | 27k | $101k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 26k | $99k | 76% | Dec 2025 |
|
| Colony | 19k | $72k | 100% | Dec 2025 |
|
| First PREMIER Bank | 19k | $71k | 0% | Dec 2025 |
|
| BlackRock | 17k | $65k | 172% | Dec 2025 |
|
| Northern Trust | 16k | $61k | 44% | Dec 2025 |
|
| Fifth Lane Capital | 15k | $56k | 100% | Dec 2025 |
|
| State Street Corporation | 13k | $49k | 100% | Dec 2025 |
|
| Kestra Advisory Services | 12k | $43k | -3% | Dec 2025 |
|
| Caxton | 11k | $39k | -4% | Dec 2025 |
|
| State of Wyoming | 9.0k | $34k | 100% | Dec 2025 |
|
| UBS Group | 7.4k | $28k | -44% | Dec 2025 |
|
| Advisor Group Holdings | 5.0k | $19k | 4% | Dec 2025 |
|
| MAI Wealth Advisors | 217.00 | $811.992300 | 0% | Dec 2025 |
|
| Gs Investments | 200.00 | $748.000000 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 87.00 | $175.000500 | 100% | Sep 2025 |
|
| Harbour Investments | 50.00 | $187.000000 | 0% | Dec 2025 |
|
| SBI Securities | 50.00 | $187.000000 | -4% | Dec 2025 |
|
Who sold out of Sab Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sphera Funds Management | Sep 2025 | 566k | $1.1M |
| Renaissance Technologies | Sep 2025 | 81k | $163k |
| Virtu Financial | Sep 2025 | 20k | $40k |
| Kovitz Investment Group Partners | Sep 2025 | 19k | $39k |
| Citadel Advisors | Jun 2025 | 17k | $30k |
| Dimensional Fund Advisors | Sep 2025 | 16k | $32k |
| Tower Research Capital | Sep 2025 | 1.6k | $3.1k |